Opioid Rotation Guidelines

Introduction to Opioid Rotation

• The National Comprehensive Cancer Network recommends considering opioid rotation for patients experiencing inadequate pain control or persistent side effects from their current therapy, such as a patient on 27.5 MME, including PRN doses 1, 2

When to Consider Opioid Rotation

• Opioid rotation should be considered when a patient has inadequate pain control despite appropriate dose titration, as recommended by the National Comprehensive Cancer Network 1
• The National Comprehensive Cancer Network suggests considering rotation when a patient experiences persistent side effects that don't resolve with supportive care 2
• Rotation may be necessary when a patient requires dose escalation but is limited by combination medication components, according to the National Comprehensive Cancer Network 2

Steps for Opioid Rotation

• The National Comprehensive Cancer Network recommends calculating the total 24-hour opioid dose, including both scheduled and as-needed doses, for patients like the one on 27.5 MME/day 2
• To select a new opioid, determine the equianalgesic dose using conversion tables, as suggested by the National Comprehensive Cancer Network 3
• If pain was effectively controlled with the current opioid, reduce the calculated equianalgesic dose by 25-50% to account for incomplete cross-tolerance, according to the National Comprehensive Cancer Network 3

Special Considerations for Specific Opioid Rotations

• When converting to transdermal fentanyl, the National Comprehensive Cancer Network recommends using the lowest available patch (25 mcg/h) for patients on low doses like 27.5 MME, and prescribing breakthrough medication during transition 4
• The National Comprehensive Cancer Network suggests avoiding mixed agonist-antagonists in combination with opioid agonist drugs, and being aware that converting from an agonist to an agonist-antagonist could precipitate withdrawal in opioid-dependent patients 2

Monitoring After Rotation

• The National Comprehensive Cancer Network recommends monitoring patients closely during the first 24-48 hours after rotation, and adjusting the dose as needed based on pain control and side effects 3, 2
• If a patient experiences unmanageable side effects, consider downward dose titration by approximately 25%, as suggested by the National Comprehensive Cancer Network 2
• For patients with persistent side effects, the National Comprehensive Cancer Network recommends considering another rotation or adjuvant therapies 1